<DOC>
	<DOCNO>NCT01766505</DOCNO>
	<brief_summary>The purpose study compare efficacy safety candesartan losartan hypertension heart failure .</brief_summary>
	<brief_title>The Study Evaluate Efficacy Safety Candesartan v Losartan Hypertension With Heart Failure ( HONOR )</brief_title>
	<detailed_description>This randomize , open-label , phase 4 study . wash period need least 14 day patient take ARB ACE inhibitor control Blood pressure . Patients take Candemore Cozzar day 16 week .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Female male patient age 19 75 Patients 90~109mmHg average sit DBP baseline NYHA class 2~4 Patients agreement write informed consent 110mmHg sit DBP and/or 180mmHg sit SBP Patients difference value 20mmHg sit SBP 10mmHg sit DBP arm screen Patients medical history secondary hypertension rule secondary hypertension malignant hypertension symptomatic postural hypotension right heart failure due pulmonary disease etc .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>hypertension , heart failure , candesartan , losartan</keyword>
</DOC>